The Clinical Lung Cancer

 The Clinical Lung Cancer is a peer-reviewed medical journal that publishes research developments related to the prevention, diagnosis and treatment of lung cancer and other thoracic malignancies. The resource for oncologists, pulmonologists, researchers and the broader medical community caring for patients with lung cancer.



The Clinical lung cancer can disrupt regular breathing and is defined as the unchecked proliferation of abnormal cells in one or both lungs. Affecting millions of people worldwide three times a year, it is one of the most common and fatal human cancers.

 

Author Benefits

We also provide many author benefits, such as a liberal copyright policy, special discounts on and much more. Please click here for more information on our website.

Regarding the article submission, please refer to Author Guidelines. For additional information or assistance, please visit our Editorial Team.


Scope

è

Anaplastic lymphoma kinase

è

Biological therapies

è

Biomarkers

è

Cancer

è

Chemoradiotherapy

è

Clinical trials

è

Comparative effectiveness

è

Concurrent chemoradiotherapy

è

Diagnosis and imaging

è

Epidermal growth factor receptor

è

Immunotherapy

è

Lung cancer

è

Lymph node

è

Pharmacoeconomics

è

Progression-free survival

è

Radiation Pneumonitis

è

Radiotherapy

è

Risk and prevention

è

Squamous cell lung cancer

è

Surgical approaches

è

Systemic therapies

è

Molecular biology of disease

è

Molecular diagnostics

è

Multivariate analysis

è

Overall survival


Comments

Popular posts from this blog

The European Journal of Cancer

The Journal of Clinical Oncology

World Journal of Clinical Surgery